Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02267694 · ClinicalTrials.gov registry record · Phase 1

Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis

A Phase 1 study, sponsored by UConn Health.

Completed
Registry status
Phase 1
Development phase
7
Enrollment target

NCT02267694: Completed Phase 1 study, sponsored by UConn Health.

NCT02267694 is a Phase 1 study that has completed, run by UConn Health. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02267694, a Phase 1 study, has completed, sponsored by UConn Health.

COMPLETED
Registry status
Phase 1
Development phase
7 participants
Enrollment target

Study Summary

This research study is about adding Black Raspberry powder to the treatment regimen of patients with ulcerative colitis who are currently in remission and doing well.

Interventions

  • DRUG Freeze-dried black raspberry powder

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2013-08
Est. Completion 2015-11-13
Phase Phase 1
UConn Health

178 total trials

What the finished NCT02267694 record still lists

NCT02267694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which Freeze-dried black raspberry powder is the first listed.

NCT02267694 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02267694 about?

NCT02267694 is a clinical study titled "Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis". This research study is about adding Black Raspberry powder to the treatment regimen of patients with ulcerative colitis who are currently in remission and doing well.

What is the current status of trial NCT02267694?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2013-08. Estimated completion is 2015-11-13.

What interventions are being tested in trial NCT02267694?

The interventions under investigation include: Freeze-dried black raspberry powder (DRUG).

Who is sponsoring clinical trial NCT02267694?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02267694's enrollment target sits among peer trials

7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02267694, the US trial registry maintained by the National Library of Medicine. NCT02267694 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.